online prescription solutions
online discount medstore
pills online
buy lorazepam without prescription
xanax for sale
buy xanax without prescription
buy ambien without prescription
ambien for sale
buy modafinil without prescription
buy phentermine without prescription
modafinil for sale
phentermine for sale
lorazepam for sale
buy lexotan without prescription
bromazepam for sale
xenical for sale
buy stilnox without prescription
valium for sale
buy prosom without prescription
buy mefenorex without prescription
buy sildenafil citrate without prescription
buy adipex-p without prescription
librium for sale
buy restoril without prescription
buy halazepam without prescription
cephalexin for sale
buy zoloft without prescription
buy renova without prescription
renova for sale
terbinafine for sale
dalmane for sale
buy lormetazepam without prescription
nobrium for sale
buy klonopin without prescription
priligy dapoxetine for sale
buy prednisone without prescription
buy aleram without prescription
buy flomax without prescription
imovane for sale
adipex-p for sale
buy niravam without prescription
seroquel for sale
carisoprodol for sale
buy deltasone without prescription
buy diazepam without prescription
zopiclone for sale
buy imitrex without prescription
testosterone anadoil for sale
buy provigil without prescription
sonata for sale
nimetazepam for sale
buy temazepam without prescription
buy xenical without prescription
buy famvir without prescription
buy seroquel without prescription
rivotril for sale
acyclovir for sale
loprazolam for sale
buy nimetazepam without prescription
buy prozac without prescription
mogadon for sale
viagra for sale
buy valium without prescription
lamisil for sale
camazepam for sale
zithromax for sale
buy clobazam without prescription
buy diflucan without prescription
modalert for sale
diflucan for sale
buy alertec without prescription
buy zyban without prescription
buy serax without prescription
buy medazepam without prescription
buy imovane without prescription
mefenorex for sale
lormetazepam for sale
prednisone for sale
ativan for sale
buy alprazolam without prescription
buy camazepam without prescription
buy nobrium without prescription
mazindol for sale
buy mazindol without prescription
buy mogadon without prescription
buy terbinafine without prescription
diazepam for sale
buy topamax without prescription
cialis for sale
buy tafil-xanor without prescription
buy librium without prescription
buy zithromax without prescription
retin-a for sale
buy lunesta without prescription
serax for sale
restoril for sale
stilnox for sale
lamotrigine for sale

USPTO to Implement New Quality Measurement System

The United States Patent and Trademark Office (USPTO) recently announced that it will be implementing a new system for measuring the quality of patent examination at the start of fiscal year 2011.  This system is designed to provide a more comprehensive analysis of patent examination to better enable its participants to identify and follow its best practices.  The new quality measurement procedures were developed by the USPTO in conjunction with the Patent Public Advisory Committee (PPAC), based largely on feedback from various entities, including individuals, law firms, corporations, intellectual property organizations, and government agencies.

The new system incorporates five additional metrics along with the two that are currently used to measure the quality of patent examination.  The current system measures the quality of the action describing the final disposition of the application, either in an allowance or a final rejection, and the quality of actions taken during the course of examination.  The new system additionally measures (1) the quality of the examiner’s initial search for prior art, (2) the use of best examination practices in the first action on the merits, (3) trends in compact and efficient examination as reflected in aggregate USPTO data, (4) the perceptions of applicants and practitioners as measured by surveys, and (5) the perceptions of examiners as measured by surveys.

First Things First

The new metrics focusing on the initial work of examiners appear to be an improvement over the current system for at least two reasons.  First, they coincide with the USPTO’s new count system for examiner production levels.  This count system was implemented in February 2010 and awards examiners more credit for their initial actions taken on applications relative to credit received for subsequent actions.  The count system was designed to decrease redundancy in subsequent actions, encourage quicker resolution of issues with applications, and spur earlier identification of patentable subject matter.  The newly added metrics should assess the effectiveness of this count system by determining compliance with the best practices associated with initial actions.  Since examiners are receiving relatively more credit for first actions than for subsequent actions, it makes sense to keep closer tabs on their initial work.  The effects of the new count system may also be analyzed by measuring the degree to which global USPTO data is indicative of compact prosecution.

A second improvement of the new metrics for examiners’ initial work is their linking of searches at the USPTO with the work product of other patent offices, such as the European Patent Office (EPO) and the Japan Patent Office (JPO).  In evaluating examiners’ use of this work product, the initial search metric relies on two factors: the proper consideration of a search report from another office as well as examiners’ notation of searching other offices for actions taken on related cases.  Work completed by other offices is a valuable resource to examiners in the U.S., and this metric should indicate how often examiners are taking advantage of this resource.  This is especially important since one study has shown that examiners rarely rely on applicant-submitted art in making rejections.

The People Have Spoken…

The new metrics involving surveys will provide subjective perceptions of quality and should encourage the participation of the public and the examining corps in identifying the best practices of patent examination.  The external quality survey addresses issues such as the availability and responsiveness of examiners to applicants’ requests as well as the overall examination quality.  The internal quality survey addresses the effectiveness of tools and training available to examiners and the degree to which applicants facilitated high-quality examination.

The USPTO will report the results of each metric as well as aggregate data used in their calculations periodically on the agency’s website.  The new quality measurement system does not attempt to alter patentability standards, nor is it used as the USPTO’s internal quality review of examiners.  However, it should serve to better educate and enable participants in the patent process to comply with existing standards and improve the overall quality of patent examination.

About the Author

Vincent Sica

Vincent Sica is a 2L at Columbia Law School
blog comments powered by Disqus